[HTML][HTML] Use of COVID-19 vaccines after reports of adverse events among adult recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 vaccines (Pfizer …
HG Rosenblum - MMWR. Morbidity and mortality weekly report, 2021 - cdc.gov
HG Rosenblum
MMWR. Morbidity and mortality weekly report, 2021•cdc.govRare serious adverse events have been reported after COVID-19 vaccination, including
Guillain-Barré syndrome (GBS) and thrombosis with thrombocytopenia syndrome (TTS) after
Janssen COVID-19 vaccination and myocarditis after mRNA (Pfizer-BioNTech and
Moderna) COVID-19 vaccination.
Guillain-Barré syndrome (GBS) and thrombosis with thrombocytopenia syndrome (TTS) after
Janssen COVID-19 vaccination and myocarditis after mRNA (Pfizer-BioNTech and
Moderna) COVID-19 vaccination.
Rare serious adverse events have been reported after COVID-19 vaccination, including Guillain-Barré syndrome (GBS) and thrombosis with thrombocytopenia syndrome (TTS) after Janssen COVID-19 vaccination and myocarditis after mRNA (Pfizer-BioNTech and Moderna) COVID-19 vaccination.
cdc.gov